Relay Therapeutics Insider Sale Sparks Stock Rally
A large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...
We evaluate which retirement option—index fund or target date fund—fits your timeline, risk profile, and tax strategy for a smoother retirement.
26,044 articlesA large insider sale at Relay Therapeutics coincides with a dramatic stock rally. This article breaks down what the r...
Ford faces renewed scrutiny as recalls mount and U.S. sales soften, fueling a debate over whether ford should give ba...
A Brooklyn rehab clinic case has public officials chasing a suspected scam spanning years. This article breaks down w...
A high-profile insider move by Pinterest’s leadership drew attention from investors. This deep dive explains what the...
A new AI-driven marketing platform is selling shares at $0.85 in a Reg A+ offering, pitched as the ChatGPT of marketi...
A rising AI marketing platform is now available through Reg A+ at $0.85 per share, aiming to become a fresh growth ve...
Translucent closed a $27 million Series A to expand its AI-native healthcare finance platform, targeting improved rev...
Binance announced a sweeping delisting of eight altcoins, sending prices lower and forcing traders to reassess holdin...
NVIDIA still leads the AI chip race, but investors are spreading bets downstream to adjacent AI opportunities as the ...
Adobe stock faces a challenging year but shows signs of a turnaround as AI monetization accelerates and enterprise de...
A new Ethereum-based play-to-earn title, Meme Punch, launches its medieval arena with MEPU rewards. The game blends m...
Berkshire Hathaway underperforming vs the S&P 500 in 2026, even as Warren Buffett’s top holdings rise. A look at why ...